Announcement
25 Jan 2024
In January 2024, the House Select Committee on the Chinese Communist Party of the US Congress proposed a bill that would restrict certain biotechnology companies from government transactions over security concerns.
Source
Number of interventions
2
0 certainly harmful
2 likely harmful
0 liberalising
Implementation date
No implementation date
Revocation date:
No revocation date
On 25 January 2024, the House Select Committee on the Chinese Communist Party of the US Congress proposed a bill, titled “BIOSECURE Act”, that restricts US government transactions with certain Chin...
On 25 January 2024, the House Select Committee on the Chinese Communist Party of the US Congress issued a draft bill, titled “BIOSECURE Act”, that restricts contracting with certain biotechnology p...
See all
This state act is not part of any Thread yet.